News In Review: Volume 10, Issue 9

U.S. trust in pharma ticks upward, but consumers still distrust the industry: survey – The good news is trust in the pharma industry is up. The bad news is that it’s still not enough to move the industry out of “distrusted” status.

Edelman’s annual trust barometer research recorded an increase of 6 points in the U.S. that helped pharma reach a new ratings score of 44. However, that’s still considered untrusted territory by Edelman; the industry would need to reach 50 to get to neutral territory and to 60 to be considered trusted under the Edelman ratings. Globally, the pharma industry’s trust rating rose 4 points to 67, ranking in the lower half of the 15 industries studied.

Our antibiotics are no match for superbugs, and it’s a ‘global crisis,’ UN report says –Common diseases such as tuberculosis are becoming untreatable while lifesaving medical procedures like surgeries carry increasing risks because of “alarming levels” of resistance to antimicrobial drugs, according to a new United Nations committee report. Resistance to antibiotics, antivirals, antifungals and antiprotozoals, which has been seen in countries of all income levels, is now a “global crisis,” the authors wrote.